Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
56580-4 Renin^20M post XXX challenge CCnc Plas Pt Qn     ACTIVE Renin [Enzymatic activity/volume] in Plasma --20 minutes post XXX challenge   MIN DefinitionDescription     ng/mL/h             CHAL   56580-4         Observation       0 Renin 20M p chal Plas-cCnc       N   20M p chal; Active renin; After; Angiotensin forming enzyme; Angiotensinogenase; Cardio; Cardiology; Catalytic Concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Heart Disease; Kidney; Nephrology; p chal; Pl; Plasma; Plasma renin activity; Plsm; Point in time; PRA; PST; QNT; Quan; Quant; Quantitative; Random; Renal 2.42 2.29               ng/mL/h       0
56581-2 Insulin^12M post XXX challenge ACnc Ser/Plas Pt Qn     ACTIVE Insulin [Units/volume] in Serum or Plasma --12 minutes post XXX challenge   MIN DefinitionDescription     mIU/mL;uIU/mL             CHAL   56581-2         Observation       0 Insulin 12M p chal SerPl-aCnc       N   12M p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.68 2.29               u[IU]/mL       0
56582-0 C peptide^10M post XXX challenge MCnc Ser/Plas Pt Qn     ACTIVE C peptide [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge   MIN DefinitionDescription     ng/mL             CHAL   56582-0         Observation       0 C peptide 10M p chal SerPl-mCnc       N   10M p chal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.34 2.29               ng/mL       0
56583-8 C peptide^45M post XXX challenge MCnc Ser/Plas Pt Qn     ACTIVE C peptide [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge   MIN DefinitionDescription     ng/mL             CHAL   56583-8         Observation       0 C peptide 45M p chal SerPl-mCnc       N   45M p chal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.34 2.29               ng/mL       0
56584-6 C peptide^12M post XXX challenge MCnc Ser/Plas Pt Qn     ACTIVE C peptide [Mass/volume] in Serum or Plasma --12 minutes post XXX challenge   MIN DefinitionDescription     ng/mL             CHAL   56584-6         Observation       0 C peptide 12M p chal SerPl-mCnc       N   12M p chal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.34 2.29               ng/mL       0
56585-3 Cortisol^45M post XXX challenge MCnc Ser/Plas Pt Qn     ACTIVE Cortisol [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge   MIN DefinitionDescription     pg/mL;ug/dL             CHAL   56585-3         Observation       0 Cortis 45M p chal SerPl-mCnc       N   17-Hydroxycorticosterone; 45M p chal; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 2.29               ug/dL       0
56586-1 Dehydroepiandrosterone^15M post XXX challenge MCnc Ser/Plas Pt Qn     ACTIVE Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge   MIN DefinitionDescription     ng/dL             CHAL   56586-1         Observation       0 DHEA 15M p chal SerPl-mCnc       N   15M p chal; After; CHEMISTRY.CHALLENGE TESTING; DHEA; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Prasterone; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.34 2.29               ng/dL       0
56587-9 Dehydroepiandrosterone^30M post XXX challenge MCnc Ser/Plas Pt Qn     ACTIVE Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge   MIN DefinitionDescription     ng/dL             CHAL   56587-9         Observation       0 DHEA 30M p chal SerPl-mCnc       N   30M p chal; After; CHEMISTRY.CHALLENGE TESTING; DHEA; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Prasterone; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.34 2.29               ng/dL       0
56588-7 Dehydroepiandrosterone sulfate^45M post XXX challenge MCnc Ser/Plas Pt Qn     ACTIVE Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge   MIN DefinitionDescription     mcg/dL; mcg/mL             CHAL   56588-7         Observation       0 DHEA-S 45M p chal SerPl-mCnc       N   45M p chal; adrenal dysfunction; After; CHEMISTRY.CHALLENGE TESTING; DHEA; DHEAS; DHEA-S; DHEA-SO4; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Prasterone; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SO4; SO4-2; SR; Sulf 2.4 2.29               ug/dL       0
56589-5 Dehydroepiandrosterone^1.5H post XXX challenge MCnc Ser/Plas Pt Qn     ACTIVE Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge   MIN DefinitionDescription     ng/dL             CHAL   56589-5         Observation       0 DHEA 1.5h p chal SerPl-mCnc       N   1 1/2 hours; 1 1/2 HR; 1.5h p chal; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; DHEA; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Prasterone; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.34 2.29               ng/dL       0
5659-8 Gold MCnc Ser/Plas Pt Qn     ACTIVE Gold [Mass/volume] in Serum or Plasma   MIN DefinitionDescription     mg/dL             DRUG/TOX   5659-8         Both       0 Gold SerPl-mCnc       Y   AU; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 1               mg/dL       0
56590-3 Dehydroepiandrosterone^2H post XXX challenge MCnc Ser/Plas Pt Qn     ACTIVE Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --2 hours post XXX challenge   MIN DefinitionDescription     ng/dL             CHAL   56590-3         Observation       0 DHEA 2h p chal SerPl-mCnc       N   120 min; 120 minutes; 120min; 2 hours; 2h p chal; After; CHEMISTRY.CHALLENGE TESTING; DHEA; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Prasterone; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.34 2.29               ng/dL       0
56591-1 Dehydroepiandrosterone sulfate^3H post XXX challenge MCnc Ser/Plas Pt Qn     ACTIVE Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --3 hours post XXX challenge   MIN DefinitionDescription     mcg/dL; mcg/mL             CHAL   56591-1         Observation       0 DHEA-S 3h p chal SerPl-mCnc       N   3h p chal; adrenal dysfunction; After; CHEMISTRY.CHALLENGE TESTING; DHEA; DHEAS; DHEA-S; DHEA-SO4; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Prasterone; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SO4; SO4-2; SR; Sulf 2.4 2.29               ug/dL       0
56592-9 Follitropin^10M post XXX challenge ACnc Ser/Plas Pt Qn     ACTIVE Follitropin [Units/volume] in Serum or Plasma --10 minutes post XXX challenge   MIN DefinitionDescription     IU/L;mIU/mL             CHAL   56592-9         Observation       0 FSH 10M p chal SerPl-aCnc       N   10M p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.38 2.29               m[IU]/mL       0
56593-7 Follitropin^3H post XXX challenge ACnc Ser/Plas Pt Qn     ACTIVE Follitropin [Units/volume] in Serum or Plasma --3 hours post XXX challenge   MIN DefinitionDescription     IU/L;mIU/mL             CHAL   56593-7         Observation       0 FSH 3h p chal SerPl-aCnc       N   3h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 2.29               m[IU]/mL       0
56594-5 Thyrotropin^3H post XXX challenge ACnc Ser/Plas Pt Qn     ACTIVE Thyrotropin [Units/volume] in Serum or Plasma --3 hours post XXX challenge   MIN DefinitionDescription     mIU/mL;uIU/mL             CHAL   56594-5         Observation       0 TSH 3h p chal SerPl-aCnc       N   3h p chal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; TSH 2.68 2.29               m[IU]/L       0
56595-2 Latex recombinant (rHev b) 3 Ab.IgE ACnc Ser Pt Qn     ACTIVE Latex recombinant (rHev b) 3 IgE Ab [Units/volume] in Serum   MIN DefinitionDescription     kIU/L             ALLERGY   56595-2         Both       0 Latex (rHev b) 3 IgE Qn       N   ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Hevea braziliensis; III; Immune globulin E; Immunoglobulin E; k082; k217; k82; Latex (rHev b) 3; Ltx; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR 2.42 2.29               k[IU]/L       0
56596-0 Latex recombinant (rHev b) 5 Ab.IgE ACnc Ser Pt Qn     ACTIVE Latex recombinant (rHev b) 5 IgE Ab [Units/volume] in Serum   MIN DefinitionDescription     kIU/L             ALLERGY   56596-0         Both       0 Latex (rHev b) 5 IgE Qn       N   ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Hevea braziliensis; Immune globulin E; Immunoglobulin E; k082; k218; k82; Latex (rHev b) 5; Ltx; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR 2.42 2.29               k[IU]/L       0
56597-8 Latex recombinant (rHev b) 8 Ab.IgE ACnc Ser Pt Qn     ACTIVE Latex recombinant (rHev b) 8 IgE Ab [Units/volume] in Serum   MIN DefinitionDescription     kIU/L             ALLERGY   56597-8         Both       0 Latex (rHev b) 8 IgE Qn       N   ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Hevea braziliensis; Immune globulin E; Immunoglobulin E; k082; k221; k82; Latex (rHev b) 8; Ltx; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR 2.42 2.29               k[IU]/L       0
56598-6 Epstein Barr virus early Ab.IgM ACnc Ser Pt Qn IA   ACTIVE Epstein Barr virus early IgM Ab [Units/volume] in Serum by Immunoassay   MIN DefinitionDescription                   MICRO   56598-6   IA     Both       0 EBV EA IgM Ser IA-aCnc       N   ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EA; EBV; EBV EA; EIA; ELFA; ELISA; Enzyme immunoassay; Epstn; HHV-4; human herpesvirus 4; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Mono; Mononucleosis; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; UniversalLabOrders 2.73 2.29               [arb'U]/mL     The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. 0
56599-4 Epstein Barr virus capsid Ab.IgM ACnc CSF Pt Qn IA   ACTIVE Epstein Barr virus capsid IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay   MIN DefinitionDescription                   MICRO   56599-4   IA     Both       0 EBV VCA IgM CSF IA-aCnc       N   ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CAP; Cerebral spinal fluid; Cerebrospinal Fl; EBV; EBV capsid Ab; EBV VCA; EIA; ELFA; ELISA; Enzyme immunoassay; Epstn; HHV-4; human herpesvirus 4; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Mono; Mononucleosis; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; VCA; Viral capsid 2.69 2.29               [arb'U]/mL     The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. 0
566-0 Cryptosporidium sp Ag PrThr XXX Pt Ord IF   ACTIVE Cryptosporidium sp Ag [Presence] in Specimen by Immunofluorescence   MIN DefinitionDescription                   MICRO   566-0   IF     Both       0 Cryptosp Ag Spec Ql IF           ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Crypt; Crypto; Cryptosporidiosis; DFA; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; species; spp; Time Resolved Fluorescence; To be specified in another part of the message; TRF; Unspecified 2.73 1                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
5660-6 Gold MCnc Urine Pt Qn     ACTIVE Gold [Mass/volume] in Urine   MIN DefinitionDescription     mg/dL             DRUG/TOX   5660-6         Both       0 Gold Ur-mCnc       Y   AU; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.73 1               mg/dL       0
56600-0 Vespa crabro Ab.IgG MCnc Ser Pt Qn     ACTIVE European Hornet IgG Ab [Mass/volume] in Serum   MIN DefinitionDescription     ug/mL             ALLERGY   56600-0         Both       0 European Hornet IgG-mCnc       N   ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; European hornet; i75; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR 2.4 2.29               ug/mL       0
56601-8 Hyaluronate MCnc Periton fld Pt Qn     ACTIVE Hyaluronate [Mass/volume] in Peritoneal fluid   MIN DefinitionDescription     ng/mL             DRUG/TOX   56601-8         Both       0 Hyaluronate Prt-mCnc       N   Ascites; Ascitic fluid; Ascitis; DRUG/TOXICOLOGY; Drugs; HA; Hyaluronan; Hyaluronic acid; Level; Mass concentration; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random 2.42 2.29               ng/mL       0
104,672 results found